In breast cancer, the tumorigenicity of tumor cells can be reduced by suppressing SOX2 expression, and restoration of SOX2 expression facilitates CSC growth, and similar phenomena have been verified in nasopharyngeal carcinoma 45, 46. The gene discussed is SOX2; the disease is nasopharyngeal carcinoma.